Top

Published in:

01-12-2012 | Review Paper

Dynamic Education of Macrophages in Different Areas of Human Tumors

Authors: Yan Wu, Limin Zheng

Published in: Cancer Microenvironment | Issue 3/2012

Abstract

Human tumor tissues can often be anatomically classified into areas of cancer nest, invading edge, and peritumoral stroma, each with distinct compositions and functional properties. Macrophages (Mφ) constitute a major component of the leukocyte infiltrate in tumors. These cells are derived from circulating monocytes, and in response to environmental signals, they exhibit distinct phenotypes with diverse functions. Soluble factors derived from cancer cells can alter the normal developmental process of Mφ that is intended to trigger transient early activation of monocytes in the peritumoral region, which in turn induces formation of suppressive Mφ in cancer nests. The activated monocytes in the peritumoral region attenuated the T-cell response by expressing B7-H1, and were superior to the suppressive tumor Mφ in inducing Th17 expansion, and thus repurpose the inflammatory response away from anti-tumor immunity (the sword) and towards tissue remodeling and proangiogenic pathways (a plowshare). In contrast, the suppressive Mφ can induce the production of Tregs in cancer nest. Accordingly, angiogenesis was most active at the invading edge, which was situated close to the peritumoral stroma with activated Mφ and the density of these activated monocytes is selectively associated with vascular invasion and metastasis in patients with hepatocellular carcinoma. These data reveal an intriguing mechanism in which human Th17 cells are generated and regulated by a fine-tuned collaborative action between different types of immune cells in distinct tumor microenvironments. These results give important new insights into the distinct role of macrophages in human tumor progression which would be helpful for the rational design of novel immune-based anticancer therapies.

Mueller MM, Fusenig NE (2004) Friends or foes—bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839–849PubMedCrossRef

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674PubMedCrossRef

van Zijl F, Mair M, Csiszar A et al (2009) Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 28:4022–4033PubMedCrossRef

Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1:119–150PubMedCrossRef

Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444PubMedCrossRef

Rabinovich GA, Gabrilovich D, Sotomayor EM (2007) Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25:267–296PubMedCrossRef

Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263–274PubMedCrossRef

Karin M, Lawrence T, Nizet V (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124:823–835PubMedCrossRef

Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612PubMedCrossRef

10.

Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964PubMedCrossRef

11.

Biswas SK, Mantovani A (2011) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11:889–896CrossRef

12.

Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8:618–631PubMedCrossRef

13.

Budhu A, Forgues M, Ye QH et al (2006) Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10:99–111PubMedCrossRef

14.

Vakkila J, Lotze MT (2004) Inflammation and necrosis promote tumour growth. Nat Rev Immunol 4:641–648PubMedCrossRef

15.

Qian BZ, Pollard JW (2011) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39–51CrossRef

16.

Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549–555PubMedCrossRef

17.

Gao B, Jeong WI, Tian Z (2008) Liver: an organ with predominant innate immunity. Hepatology 47:729–736PubMedCrossRef

18.

Liu H, Pan Z, Li A et al (2008) Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Cell Mol Immunol 5:373–378PubMedCrossRef

19.

Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917PubMedCrossRef

20.

Xu J, Ding T, He Q et al (2012) In situ molecular signature predict early recurrence in Hepatitis B virus-related hepatocellular carcinoma. J Hepatol, in press

21.

Shi C, Pamer EG (2011) Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11:762–774PubMedCrossRef

22.

Taylor PR, Martinez-Pomares L, Stacey M et al (2005) Macrophage receptors and immune recognition. Annu Rev Immunol 23:901–944PubMedCrossRef

23.

Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11:750–761PubMedCrossRef

24.

Kuang DM, Wu Y, Chen N et al (2007) Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 110:587–595PubMedCrossRef

25.

Martinez FO, Helming L, Gordon S (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27:451–483PubMedCrossRef

26.

Krausgruber T, Blazek K, Smallie T et al (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 12:231–238PubMedCrossRef

27.

He M, Xu Z, Ding T, Kuang DM, Zheng L (2009) MicroRNA-155 regulates inflammatory cytokine production in tumor-associated macrophages via targeting C/EBPbeta. Cell Mol Immunol 6:343–352PubMedCrossRef

28.

Cheng J, Huo DH, Kuang DM et al (2007) Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells. Cancer Res 67:5141–5147PubMedCrossRef

29.

Yang M, Chen J, Su F et al (2011) Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 10:117PubMedCrossRef

30.

Lewis CE, De Palma M, Naldini L (2007) Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res 67:8429–8432PubMedCrossRef

31.

Qian BZ, Li J, Zhang H et al (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475:222–225PubMedCrossRef

32.

Fu J, Xu D, Liu Z et al (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132:2328–2339PubMedCrossRef

33.

Gao Q, Qiu SJ, Fan J et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586–2593PubMedCrossRef

34.

Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295–307PubMedCrossRef

35.

Zhou J, Ding T, Pan W et al (2009) Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Int J Cancer 125:1640–1648PubMedCrossRef

36.

Lob S, Konigsrainer A, Rammensee HG, Opelz G, Terness P (2009) Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 9:445–452PubMedCrossRef

37.

Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762–774PubMedCrossRef

38.

Godin-Ethier J, Pelletier S, Hanafi LA et al (2009) Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. J Immunol 183:7752–7760PubMedCrossRef

39.

Zhao Q, Kuang DM, Wu Y et al (2012) Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages. J Immunol 188:1117–1124PubMedCrossRef

40.

Kuang DM, Peng C, Zhao Q et al (2010) Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells. Hepatology 51:154–164PubMedCrossRef

41.

Ding T, Xu J, Wang F et al (2009) High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum Pathol 40:381–389PubMedCrossRef

42.

Kuang DM, Peng C, Zhao Q et al (2010) Tumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients. J Immunol 185:1544–1549PubMedCrossRef

43.

Kuang DM, Zhao Q, Peng C et al (2009) Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med 206:1327–1337PubMedCrossRef

44.

Kuang DM, Zhao Q, Wu Y et al (2011) Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol 54:948–955PubMedCrossRef

45.

Greenwald RJ, Freeman GJ, Sharpe AH (2005) The B7 family revisited. Annu Rev Immunol 23:515–548PubMedCrossRef

46.

Zou W, Chen L (2008) Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 8:467–477PubMedCrossRef

47.

Hou J, Tian L, Wei Y (2004) Cancer immunotherapy of targeting angiogenesis. Cell Mol Immunol 1:161–166PubMed

48.

Weis SM, Cheresh DA (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17:1359–1370PubMedCrossRef

49.

Lewis CE, Hughes R (2007) Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2. Breast Cancer Res 9:209PubMedCrossRef

50.

Lewis C, Murdoch C (2005) Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 167:627–635PubMedCrossRef

51.

Xu S, Cao X (2010) Interleukin-17 and its expanding biological functions. Cell Mol Immunol 7:164–174PubMedCrossRef

52.

Zou W, Restifo NP (2010) T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 10:248–256PubMedCrossRef

53.

Zhang JP, Yan J, Xu J et al (2009) Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 50:980–989PubMedCrossRef

54.

Su X, Ye J, Hsueh EC et al (2010) Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184:1630–1641PubMedCrossRef

55.

Yen HR, Harris TJ, Wada S et al (2009) Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol 183:7161–7168PubMedCrossRef

56.

Li J, Huang ZF, Xiong G et al (2011) Distribution, characterization, and induction of CD8 regulatory T cells and IL-17-producing CD8 T cells in nasopharyngeal carcinoma. J Transl Med 9:189PubMedCrossRef

57.

Wang L, Yi T, Kortylewski M et al (2009) IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 206:1457–1464PubMedCrossRef

58.

Kryczek I, Wei S, Zou L et al (2007) Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol 178:6730–6733PubMed

59.

Muranski P, Boni A, Antony PA et al (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112:362–373PubMedCrossRef

60.

Nathan C (2006) Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6:173–182PubMedCrossRef

61.

Wu Y, Zhao Q, Peng C et al (2011) Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. J Pathol 225:438–447PubMedCrossRef

62.

Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992–1009PubMedCrossRef

63.

Kessenbrock K, Plaks V, Werb Z (2011) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67CrossRef

64.

Shi GM, Ke AW, Zhou J et al (2010) CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology 52:183–196PubMedCrossRef

65.

Zhao Q, Xiao X, Wu Y et al (2011) Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients. Eur J Immunol 41:2314–2322PubMedCrossRef

Title: Dynamic Education of Macrophages in Different Areas of Human Tumors
Authors: Yan Wu
Limin Zheng
Publication date: 01-12-2012
Publisher: Springer Netherlands
Published in: Cancer Microenvironment / Issue 3/2012
Print ISSN: 1875-2292
Electronic ISSN: 1875-2284
DOI: https://doi.org/10.1007/s12307-012-0113-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2012

Role of p63 in Development, Tumorigenesis and Cancer Progression

Multifaceted Tumor Stromal Fibroblasts

Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy

Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers?

Molecular Regulation of Lymphangiogenesis in Development and Tumor Microenvironment

The Plexiform Neurofibroma Microenvironment

Keynote webinar | Spotlight on antibody–drug conjugates in cancer